Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169

NCT04150224 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: PBTZ169 640 mg OD
DRUG: PBTZ169 640 mg BiD
DRUG: PBTZ169 960 mg SD
DRUG: PBTZ169 1280 mg SD
DRUG: PBTZ169 1280 mg MD

Sponsor

Nearmedic Plus LLC